Termination of the Neramexane tinnitus treatment licensing agreement with Merz
A standalone event involving the termination of the foreign technology licensing agreement for Neramexane, a tinnitus treatment licensed from Merz. The theme concerns a specific drug, licensor and contract termination.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.